Sindrome.del.Ovario.Poliquistico

98 Síndrome del Ovario Poliquístico
63
Rodríguez-Espinosa J. Hiperandrogenismo.
Diagnóstico bioquímico. Cuad Med
Reprod. 1996;2:99-116.
64
Cussons AJ, Stuckey BG, Walsh JP,
Burke V, Norman RJ. Polycystic ovarian
syndrome: marked differences between
endocrinologists and gynaecologists in
diagnosis and management. Clin Endocrinol
(Oxf). 2005;62:289-95.
65
Fraser IS, Kovacs G. Current recommendations
for the diagnostic evaluation
and follow-up of patients presenting
with symptomatic polycystic ovary
syndrome. Best Pract Res Clin Obstet
Gynaecol. 2004;18:813-23.
66
Dueñas JL, Cano A, Castelo-Branco C,
Espinós JJ, Marín JM, et al. Síndromes
hiperandrogénicos. Documentos de Consenso
SEGO; 1998. p. 107-43.
67
Chang RJ. A practical approach to
the diagnosis of polycystic ovary syndrome.
Am J Obstet Gynecol. 2004;191:
713-7.
68
Homburg R. What is polycystic ovarian
syndrome? A proposal for a consensus
on the definition and diagnosis of polycystic
ovarian syndrome. Hum Reprod.
2002;17:2495-9.
69
Adams J, Franks S, Polson DW, Mason
HD, Abdulwahid N, Tucker M, et al.
Multifollicular ovaries: clinical and endocrine
features and response to pulsatile
gonadotropin releasing hormone. Lancet.
1985;2:1375-9.
70
Azziz R. Androgen excess is the key
element in polycystic ovary syndrome.
Fertil Steril. 2003;80:252-4.
71
Paulson RJ. The insulin resistant subphenotype
of polycystic ovary syndrome:
clinical parameters and pathogenesis.
Am J Obstet Gynecol. 2004;1906:1654-60.
72
Dunaif A, Segal KR, Futterweit W,
Dobrjansky A. Profound peripheral insulin
resistance, independent of obesity,
in polycystic ovary syndrome. Diabetes.
1989;38:1165-74.